ETFMG Alternative Harvest ETF (MJ)
21.09
+0.17 (+0.81%)
USD |
Apr 16, 20:00
Price Chart
Key Stats
Customize
| Expense Ratio | Discount or Premium to NAV | Total Assets Under Management | 30-Day Average Daily Volume |
|---|---|---|---|
| 0.75% | -0.05% | 1.694B | 1.629M |
| Dividend Yield | Turnover Ratio | 1 Year Fund Level Flows | Max Drawdown (All) |
| 2.75% | 46.00% | 591.80M | Upgrade |
Basic Info
| Investment Strategy | |
| The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the Prime Alternative Harvest Index. The index is concentrated in the Pharmaceuticals, Biotechnology and Life Sciences group of industries and tracks the performance of the exchange-listed common stock (or corresponding ADRs or GDRs) of companies across the globe. The fund will invest at least 80% of its total assets, exclusive of collateral held from securities lending, in the component securities of the index and in ADRs and GDRs based on the component securities in the index. The fund is non-diversified. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Mid Cap/Growth |
| Fixed Income Style | -- |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Miscellaneous Sector |
| Category Index | Morningstar US Market TR USD |
| Prospectus Objective | Specialty - Unaligned |
| Fund Owner Firm Name | ETFMG |
| Prospectus Benchmark Index | |
| Prime Alternative Harvest NR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
| Manager Tenure | |
| Devin Ryder | 2.90 yrs |
| Samuel Masucci | 2.90 yrs |
| Donal Bishnoi | 1.50 yrs |
| Frank Vallario | 1.50 yrs |
Net Fund Flows Versus Category
1 Month
% Rank:
--
--
Category Low
--
Category High
1 Year
% Rank:
23
591.80M
-2.143M
Category Low
4.417B
Category High
3 Months
% Rank:
--
--
Category Low
--
Category High
3 Years
% Rank:
--
--
Category Low
--
Category High
6 Months
% Rank:
--
--
Category Low
--
Category High
5 Years
% Rank:
--
--
Category Low
--
Category High
YTD
% Rank:
--
--
Category Low
--
Category High
10 Years
% Rank:
--
--
Category Low
--
Category High
As of March 31, 2021
Performance Versus Category
As of April 16, 2021. Returns for periods of 1 year and above are annualized.
Annual Total Returns Versus Peers
Edit comparables
As of April 16, 2021.
Asset Allocation
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| GW Pharmaceuticals PLC ADR | 11.29% | 218.90 | 0.04% |
| Aphria Inc | 8.36% | 17.69 | 4.06% |
| GrowGeneration Corp | 5.88% | 47.10 | 0.64% |
| Tilray Inc | 5.29% | 17.20 | 1.53% |
| Canopy Growth Corp | 5.26% | 34.76 | 1.22% |
| Cronos Group Inc | 4.57% | 10.43 | 2.56% |
| Schweitzer-Mauduit International Inc | 4.39% | 49.74 | 0.26% |
| Altria Group Inc | 4.13% | 52.31 | 1.36% |
| Vector Group Ltd | 4.10% | 14.49 | 0.00% |
| Philip Morris International Inc | 3.85% | 92.91 | 1.18% |
News
Headline
Wire
Time (ET)
SA Breaking News
04/12 08:12
SA Breaking News
03/11 07:52
Basic Info
| Investment Strategy | |
| The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of the Prime Alternative Harvest Index. The index is concentrated in the Pharmaceuticals, Biotechnology and Life Sciences group of industries and tracks the performance of the exchange-listed common stock (or corresponding ADRs or GDRs) of companies across the globe. The fund will invest at least 80% of its total assets, exclusive of collateral held from securities lending, in the component securities of the index and in ADRs and GDRs based on the component securities in the index. The fund is non-diversified. |
| General | |
| Security Type | Exchange-Traded Fund |
| Equity Style | Mid Cap/Growth |
| Fixed Income Style | -- |
| Broad Asset Class | Sector Equity |
| Broad Category | Equity |
| Category Name | Miscellaneous Sector |
| Category Index | Morningstar US Market TR USD |
| Prospectus Objective | Specialty - Unaligned |
| Fund Owner Firm Name | ETFMG |
| Prospectus Benchmark Index | |
| Prime Alternative Harvest NR USD | 100.0% |
| Broad Asset Class Benchmark Index | |
| ^MSWNTR | 100.0% |
| Manager Tenure | |
| Devin Ryder | 2.90 yrs |
| Samuel Masucci | 2.90 yrs |
| Donal Bishnoi | 1.50 yrs |
| Frank Vallario | 1.50 yrs |
Fundamentals
| General | |
| Distribution Yield | Upgrade |
| Dividend Yield TTM (4-16-21) | 2.75% |
| 30-Day SEC Yield (4-1-21) | Upgrade |
| 7-Day SEC Yield | -- |
| Number of Holdings | Upgrade |
| Stock | |
| Weighted Average PE Ratio | -- |
| Weighted Average Price to Sales Ratio | Upgrade |
| Weighted Average Price to Book Ratio | Upgrade |
| Weighted Median ROE | Upgrade |
| Weighted Median ROA | Upgrade |
| Forecasted Dividend Yield | Upgrade |
| Forecasted PE Ratio | Upgrade |
| Forecasted Price to Sales Ratio | Upgrade |
| Forecasted Price to Book Ratio | Upgrade |
As of April 16, 2021
Growth Estimates
Fund Details
| Key Dates | |
| Inception Date | 12/3/2015 |
| Last Annual Report Date | 9/30/2020 |
| Last Prospectus Date | 1/29/2021 |
| Attributes | |
| Enhanced Index Fund | No |
| Index Fund |
|
| Inverse Fund | No |
| Leveraged Fund | No |
| Fund of Funds | No |
| Currency Hedged Fund | No |
| Synthetic Replication Fund | No |
| Has Dividend Investment Plan | No |
| Socially Responsible Fund | No |
News
Headline
Wire
Time (ET)
SA Breaking News
04/12 08:12
SA Breaking News
03/11 07:52